Stablepharma and BB-NCIPD Ltd (Bul Bio) sign exclusive supply agreement to produce the world’s first fridge-free Tetanus diphtheria vaccine

Published at: 2022-09-29

Stablepharma

More news and events

Stablepharma and Partner BB-NCIPD Ltd (Bul Bio) sign a second exclusive supply agreement to develop a fridge-free Tetanus mono vaccine.

Stablepharma and Partner BB-NCIPD Ltd (Bul Bio) sign a second exclusive supply agreement to develop a fridge-free Tetanus mono vaccine.

2023-05-25

Stablepharma and Partner BB-NCIPD Ltd (Bul Bio) sign a second exclusive supply agreement to develop a fridge-free Tetanus mono vaccine. read more ...

Stablepharma and BB-NCIPD Ltd (Bul Bio) sign exclusive supply agreement

Stablepharma and BB-NCIPD Ltd (Bul Bio) sign exclusive supply agreement

2022-09-29

Stablepharma and BB-NCIPD Ltd (Bul Bio) sign exclusive supply agreement read more ...

BB-NCIPD Ltd. (Bul Bio) and Stablepharma Ltd. have entered into partnership to produce the world’s first fridge free Tetanus Diphtheria vaccine

BB-NCIPD Ltd. (Bul Bio) and Stablepharma Ltd. have entered into partnership to produce the world’s first fridge free Tetanus Diphtheria vaccine

2021-03-19

BB-NCIPD Ltd. read more ...

"Caps for the future"

2020-07-14

"Caps for the future" read more ...

ENVIRONMENT POLICY

ENVIRONMENT POLICY

2019-06-05

ENVIRONMENT POLICY read more ...

GMP certificate from Turkey

GMP certificate from Turkey

2015-06-30

BB - NCIPD Ltd. received GMP certificate read more ...

Copyright © 2003-2023 BB - NCIPD Ltd.